GO
Loading...

Medicine

More

  • All In The Family Tuesday, 14 Jul 2009 | 11:34 AM ET
    Mike and his sister.

    For years now, but especially in recent months, I've been covering the obesity epidemic. I regularly report on the statistics and the experimental drug data, detached and "objective" as I think any good reporter should be. It just didn't occur to me that the target population might include my sister.

  • Is Lilly's Effient Sufficient? Monday, 13 Jul 2009 | 11:28 AM ET

    I was wrong. I'd blogged a few times that I thought the FDA might have a problem with "Effient," Eli Lilly's proposed name for its bloodthinner, because it was too close to efficient and all the connotations that would have.

  • It's a Numbers Game for Merck & Glaxo Tuesday, 7 Jul 2009 | 12:49 PM ET

    Perhaps reflecting concerns about the size and growth of the market for HPV shots and GSK's late entry, investors are not enthusiastic about the prestigious publication of the company's robust new test results. As I write this, GSK shares are the biggest percentage loser in big pharma.

  • Hey, What's Up Doc? Monday, 6 Jul 2009 | 11:55 AM ET
    Bugs Bunny

    Could a carrot-chomping Bugs Bunny become a drug pitchman? Well, maybe, if the small Israeli company Protalix BioTherapeutics could pay Warner Brothers enough money for Bugs' services.

  • FDA: Thinking Outside The Black Box Wednesday, 1 Jul 2009 | 3:25 PM ET
    Zyban Prescribing Information

    Today the Food and Drug Administration announced that Pfizer's Chantix and GlaxoSmithKline's Zyban will carry new warnings about mental side effects. Not just any old warnings, but so-called "Black Box" warnings. Or, at least, that's what we in the news media used to call them. Until the FDA called us out today.

  • Looking For The Lantus Leak Monday, 29 Jun 2009 | 11:23 AM ET
    Sanofi Aventis

    Shares of Sanofi-Aventis are getting a little investor injection on the back of the emergency release of the Lantus diabetic insulin studies late last Friday.

  • A Sanofi Safety Scare? Friday, 26 Jun 2009 | 1:18 PM ET
    Sanofi Aventis

    Shares of the French drugmaker are getting pummeled over at least three analyst reports identifying a leak about a study or studies that could go public soon. Their research suggests the data is related to a suspected or "theoretical" higher cancer risk associated with SNY's Lantus.

  • Obama and Congress Clash on How to Pay for Health Care Friday, 26 Jun 2009 | 10:48 AM ET
    President Barack Obama

    It has become the trillion-dollar question: can President Obama find that much in spending cuts and tax increases to keep his campaign promise to overhaul the health care system, without adding to already huge deficits? Mr. Obama and the Democrats running Congress are deeply split over the possibilities.

  • The Boston Scientific Tobin Party Thursday, 25 Jun 2009 | 1:27 PM ET

    Man, it's gotta hurt when the publicly-traded company you've been leading for years announces you're stepping down and investors pop the champagne corks.

  • Crucell's Lovely RITA Wednesday, 24 Jun 2009 | 2:11 PM ET
    Rabies in the Americas 2009

    ACC, ADA, AHA, ASCO, ICAD, TCT. That's just a handful of the acronyms and abbreviations for scientific and medical conferences that I've attended over the years. But this year I might be able to add RITA to my dance card. I'd never heard of her (it) before this morning when I got this press release from Crucell, which owns technology for faster, better, cheaper vaccine manufacturing.

  • A Jobs Tip & A Tweet Monday, 22 Jun 2009 | 12:46 PM ET
    Apple CEO Steve Jobs introduces the new iPod Nano in San Francisco, Tuesday, Sept. 9, 2008.

    The growing, influential role of Twitter has never been more evident than during the recent Iranian uprising. But did the story that "The Wall Street Journal" broke last Friday night about Apple's Steve Jobs getting a liver transplant actually appear on Twitter first?

  • Healthcare Stocks Getting Healthy Thursday, 18 Jun 2009 | 3:06 PM ET

    Healthcare stocks rebound, so is significant reform dead? Healthcare stocks have been moving off their lows since Tuesday and are up significantly today after moving almost straight down in June.

  • A Nose For News On Matrixx's Zicam Thursday, 18 Jun 2009 | 12:34 PM ET

    Two days after the FDA ordered Matrixx Initiatives' Zicam off the market the story remains one of the most emailed articles on "The New York Times" website. And the company seems to still be trying to find its corporate crisis footing.

  • The Zicam Matrixx Wednesday, 17 Jun 2009 | 12:41 PM ET
    Zicam

    I was an early adopter of Zicam when it came on the market 10 years ago. Whenever I felt a cold coming on, I'd load up on the stuff along with Vitamin C and zinc lozenges. So, last night I went searching through the bathroom cabinets to find my Zicam stash to toss it in the trash per the FDA's advisory.

  • Health Care Rationing Rhetoric Overlooks Reality Wednesday, 17 Jun 2009 | 11:21 AM ET

    The r-word has become a rejoinder to anyone who says that this country must reduce its runaway health spending, especially anyone who favors cutting back on treatments that don’t have scientific evidence behind them. You can expect to hear a lot more about rationing as health care becomes the dominant issue in Washington this summer.

  • Taking A Weight Off My Shoulder Monday, 15 Jun 2009 | 1:27 PM ET
    Lipitor

    I have a confession to make. I try to be as transparent as possible, to share as much information as I can about how the sausage is made. To that end, on at least a few occasions I’ve mentioned on this blog and on CNBC, that I’ve been on 10 milligrams of Lipitor.

  • Beach Blanket Biotech Friday, 12 Jun 2009 | 1:10 PM ET

    This morning the apparently Red Bull-fueled (or maybe he's a Starbucks triple-shot guy) biotech analyst at Deutsche Bank, Dr. Mark Schoenebaum, did a deep dive for clients in a presentation he called, "Getting ready for summer!"

  • A Shot In The Bottom Line Thursday, 11 Jun 2009 | 3:16 PM ET
    Pharma Stocks

    To almost no one's surprise, for the first time in 41 years, the World Health Organization has declared a full-blown swine flu pandemic. But the declaration is tied more to the geographic spread of the virus than it is to its virulence.

  • Medtronic Clarifies CEO Hawkins Statement On Consultant Wednesday, 10 Jun 2009 | 12:24 PM ET

    Medtronic spokesman Steve Cragle sent CNBC this clarification to Mr. Hawkins' answer to Mike Huckman's question regarding the Senate investigation into a doctor who has done consulting work for MDT.

  • Merck Puts That Drug Back On The Shelf Friday, 5 Jun 2009 | 12:50 PM ET
    Risky Business

    "It's a risky business." I don't think I'll ever forget when a Chief Financial Officer said that at an investor conference last year in lieu of reading the whole boring boilerplate "Safe Harbor Statement."